Patent details
300751
Product Name:
Secukinumab.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300751
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1641822
Status:
Withdrawn
Application number:
300751
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/14/980
Marketing Authorization Type:
EEA
Marketing Authorization Date:
15/01/2015
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
15/07/2015
First Marketing Authorization date:
15/01/2015
Grant date:
Activation date:
02/06/2024
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
15/07/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
20/04/2020
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
15/07/2015
Name:
Genentech, Inc.
Address:
1 DNA Way, SOUTH SAN FRANCISCO, CA 94080-4990, United States of America (US)
Agent
Name:
ir. H.A. Witmans c.s.
From:
15/07/2015
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
31/20
Publication date:
31/07/2020
Description:
Contains data concerning lapse or annulment
2
Bulletin Heading:
VRV
Journal edition number:
17/20
Publication date:
22/04/2020
Description:
Contains data concerning lapse or annulment
3
Bulletin Heading:
SPC
Journal edition number:
2015/31
Publication date:
29/07/2015
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
Filing date
Document type
Document Description
Number of pages
21/04/2020
Outgoing Correspondence
Letter confirmation withdrawal
1
/1/5/7/0/0/0400300751/docs/300751_2_340059l193.pdf
06/03/2019
Outgoing Correspondence
Letter communication third party to holder
1
/1/5/7/0/0/0400300751/docs/300751_0_257682l035.pdf
06/03/2019
Outgoing Correspondence
Letter communication third party to holder
1
/1/5/7/0/0/0400300751/docs/300751_5_257678l035.pdf
21/02/2019
Incoming Correspondence Paper
Incoming Correspondence Paper
2
/1/5/7/0/0/0400300751/docs/300751_3_incomingcorrespondencepaper20190225085040730.pdf
21/01/2016
Outgoing Correspondence
Letter to applicant
1
/1/5/7/0/0/0400300751/docs/300751_8_outgoingcorrespondence20200330031404387.pdf
09/10/2015
Incoming Correspondence Paper
Accompanying letter incoming document
1
/1/5/7/0/0/0400300751/docs/300751_4_incomingcorrespondencepaper20151020040716206.pdf
11/08/2015
Outgoing Correspondence
Outgoing Letter
3
/1/5/7/0/0/0400300751/docs/300751_10_outgoingcorrespondence20150812.pdf
17/07/2015
Outgoing Correspondence
Outgoing Letter
1
/1/5/7/0/0/0400300751/docs/300751_6_outgoingcorrespondence20150717.pdf
16/07/2015
SPC Documents
Marketing Authorization SPC
3
/1/5/7/0/0/0400300751/docs/300751_1_supplprotectioncertificate20200330033730466.pdf
16/07/2015
Application Form
First filed application form
3
/1/5/7/0/0/0400300751/docs/300751_7_applicationform20150716.pdf
16/07/2015
SPC Documents
Summary of the characteristics of the product
84
/1/5/7/0/0/0400300751/docs/300751_9_supplprotectioncertificate20200330032743120.pdf